Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Robert Stuver(Memorial Sloan Kettering Cancer Center), Santosha A. Vardhana(Memorial Sloan Kettering Cancer Center), David J. Straus(Memorial Sloan Kettering Cancer Center), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center), Audrey Hamilton(Memorial Sloan Kettering Cancer Center), Ariela Noy(Memorial Sloan Kettering Cancer Center), Gunjan L. Shah(Cornell University), Urvi A. Shah(United States Fish and Wildlife Service), Richard J. Lin(Cornell University), Ann A. Jakubowski(Memorial Sloan Kettering Cancer Center), Sital Doddi(Memorial Sloan Kettering Cancer Center), James W. Young(Memorial Sloan Kettering Cancer Center), Heather L. Landau(Memorial Sloan Kettering Cancer Center), Lindsey E. Roeker(Memorial Sloan Kettering Cancer Center), Connie Lee Batlevi(Memorial Sloan Kettering Cancer Center), Michael Scordo(Cornell University), Lakshmi V. Ramanathan(Memorial Sloan Kettering Cancer Center), David J. Chung(Memorial Sloan Kettering Cancer Center), Sham Mailankody(Memorial Sloan Kettering Cancer Center), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Neha Korde(United States Fish and Wildlife Service), Doris M. Ponce(Memorial Sloan Kettering Cancer Center), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Boglarka Gyurkocza(Cornell University), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Anthony R. Mato(Memorial Sloan Kettering Cancer Center), Gilles Salles(Memorial Sloan Kettering Cancer Center), Lorenzo Falchi(Memorial Sloan Kettering Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Susan K. Seo(Memorial Sloan Kettering Cancer Center), Ya-Hui Lin(Memorial Sloan Kettering Cancer Center), Erel Joffe(Memorial Sloan Kettering Cancer Center)
Cited by 88
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k